Literature DB >> 819685

In vivo studies on protease and elastase from Pseudomonas aeruginosa.

K Kawaharajo, J Y Homma, Y Aoyama, K Morihara.   

Abstract

Protease and elastase from Pseudomonas aeruginosa were inoculated in female mice by intravenous, intraperitoneal, intrapleural and intranasal route, and the lethality and damage of various organs were examined. The protease and elastase exhibited respectively the following minimum lethal dose (MLD) values in 24 hr; 300 and 375 mug inoculated intravenously; 200 and 125-250 mug intraperitoneally; and 100 and 62.5 mug intrapleurally. The instillation of a defined dose of the enzyme by the intranasal route was difficult to control, therefore the MLD could not be defined exactly. The protease and elastase were capable of eliciting hemorrhage at various organs of mice according to the route of inoculation. Of protease, intravenous injections elicited petechial hemorrhage at the lungs and parietal bone-area, and severe one in the medullary area of kidney. The intraperitoneal injection resulted in petechial hemorrhage of the lungs, diaphragm, peritoneum and gastrointestinal serosa. Intrapleural injections and intranasal instillation resulted in confluent pulmonary hemorrhage. Of elastase, intravenous injections elicited confluent pulmonary hemorrhage, hemorrhage in the medullary area of kidney and cerebral ventricles, and petechial hemorrhage at the stomach-walls. The intraperitoneal injections resulted in petechial hemorrhage at the lungs, diaphragm, peritoneum and gastointestinal serosa. Intrapleural injections resulted in confluent pulmonary hemorrhage, and petechiae at the diaphragm and pleura. Intranasal instillation resulted in confluent pulmonary hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 819685

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  15 in total

1.  A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.

Authors:  P A Sokol; D E Ohman; B H Iglewski
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

2.  Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.

Authors:  Ali O Azghani; Kourtney Neal; Steven Idell; Rodolfo Amaro; Jason W Baker; Abdelwahab Omri; Usha R Pendurthi
Journal:  Microbiology (Reading)       Date:  2014-01-02       Impact factor: 2.777

3.  Effects of Pseudomonas aeruginosa elastase on alveolar epithelial permeability in guinea pigs.

Authors:  A O Azghani; J C Connelly; B T Peterson; L D Gray; M L Collins; A R Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Disruption of respiratory cilia by proteases including those of Pseudomonas aeruginosa.

Authors:  S T Hingley; A T Hastie; F Kueppers; M L Higgins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

5.  Production of protease and elastase by Pseudomonas aeruginosa strains isolated from patients.

Authors:  K Morihara; H Tsuzuki
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

6.  Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases.

Authors:  L Gray; A Kreger
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

7.  Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor.

Authors:  K Morihara; H Tsuzuki; K Oda
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

8.  Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection.

Authors:  O R Pavlovskis; B Wretlind
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

9.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

10.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.